Leading group in brain metastasis research predicts mid-term advances that will improve patients’ lives

by CNIO - Centro Nacional de Investigaciones Oncológicas

Two clinical trials, a tool to determine which drug works best for each patient, and the first bank of living samples of brain metastases are some of the achievements of the CNIO group.

Read more

Diario de un Dato en Farmacovigilancia: Mi Viaje Hacia una Base de Datos Innovadora

by León Research

Ser un dato en farmacovigilancia implica responsabilidad. Mi viaje – desde el formulario hasta el sistema electrónico – existe para asegurar que cada señal pueda detectarse, entenderse y actuar ...

Read more

Una investigación de la UMU descubre un tratamiento potencial para la anemia de Diamond-Blackfan con fármacos ya existentes

by Universidad de Murcia

Han identificado varios fármacos ya aprobados por las agencias reguladoras que podrían convertirse en un nuevo tratamiento para la anemia de Diamond-Blackfan (DBA), una enfermedad rara caracterizada...

Read more

The myth of the 'superwoman'

by bioNova

The cultural myth of the “superwoman” idealizes women who are perceived as effortlessly able to balance demanding careers, caregiving responsibilities, social life, and personal goals. While often...

Read more

Choosing the Right CDMO Partner in Biopharma: Your Molecule Deserves the Right Partner

by 3PBIOVIAN

In today’s rapidly evolving biopharmaceutical landscape, selecting the right Contract Development and Manufacturing Organization (CDMO) is one of the most strategic decisions a company can make. Whe...

Read more

Sant Pau Research Institute Secures More Than €2.5 Million to Advance Two Independent Clinical Trials in Oncology and Stroke

by Hospital de la Santa Creu i Sant Pau

The Sant Pau Research Institute (IR Sant Pau) will lead two new independent clinical trials in areas of high clinical complexity—hematologic oncology and acute ischemic stroke—after securing more ...

Read more

Potential new first-line treatment strategy for patients with BRAF V600E-mutant metastatic colorectal cancer

by VHIO

The BREAKWATER open-label, randomized phase 3 study was designed to evaluate first-line treatment with targeted therapies encorafenib and cetuximab plus chemotherapy compared to standard of care in pa...

Read more

Drug-Resistant Focal Epilepsy: Clinical Trials and Emerging Therapies. Transforming Patient Care Through Innovation

by Pivotal

Drug-resistant epilepsy (DRE) is one of the most significant challenges in modern neurology. Affecting approximately 15-16 million people worldwide—about 30% of all individuals with epilepsy¹—thi...

Read more

A study evaluates ketamine in resistant depression as an alternative to electroconvulsive therapy

by Instituto de Investigación e Innovación Parc Taulí

It has been initiated a clinical trial with 70 patients with resistant depression who are currently receiving maintenance ECT. The main objective of the study is to determine whether switching to keta...

Read more

Atlas Molecular Pharma closes a €3 million funding round led by Inveready to advance its clinical program in rare diseases

by Inveready

Atlas Molecular Pharma (Atlas), a biotechnology company and spin-off of CIC bioGUNE, has closed a €3 million investment round aimed at driving the clinical development of ATL-001, its oral clinical-...

Read more

Seguir la dieta mediterránea durante el embarazo mejora la microbiota intestinal de la madre

by Hospital Sant Joan de Déu

La microbiota intestinal, formada por los microorganismos que habitan en el intestino, desempeña un papel clave en la digestión, el metabolismo y la regulación del sistema inmunitario. Durante el e...

Read more

An international study confirms two equally effective treatment options for patients with advanced pancreatic neuroendocrine tumours

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

The research analyzes for the first time the order of administration of the drug everolimus and the treatment of STZ/5-FU chemotherapy in patients with advanced disease and shows that, while treatment...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream